IL-10 predicts the prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure combined with spontaneous bacterial peritonitis

BackgroundSpontaneous bacterial peritonitis (SBP) is common in patients with hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF). The prognostic value of interleukin-related serum markers for patients with ACLF is coming to the fore. However, there is an unmet need to predict the sur...

Full description

Bibliographic Details
Main Authors: Linxiang Liu, Nanxi Xiao, Peng Chen, Xuan Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1188300/full
_version_ 1797672488343175168
author Linxiang Liu
Linxiang Liu
Nanxi Xiao
Nanxi Xiao
Peng Chen
Peng Chen
Xuan Zhu
Xuan Zhu
author_facet Linxiang Liu
Linxiang Liu
Nanxi Xiao
Nanxi Xiao
Peng Chen
Peng Chen
Xuan Zhu
Xuan Zhu
author_sort Linxiang Liu
collection DOAJ
description BackgroundSpontaneous bacterial peritonitis (SBP) is common in patients with hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF). The prognostic value of interleukin-related serum markers for patients with ACLF is coming to the fore. However, there is an unmet need to predict the survival of such patients. We aimed to analyze the independent predictors of 28- and 90-day mortality in HBV-ACLF patients with SBP.MethodsThis was a retrospective study that included 368 patients with HBV-ACLF. In the SBP group, logistic regression analysis was used to understand the independent predictors of mortality at 28-day and 90-day. The accuracy of prediction was analyzed using the area under the receiver operating characteristic curve (AUROC). Finally, decision curve analysis (DCA) was used to determine the clinical utility value.ResultsInterleukin 10 (IL-10) levels were statistically significantly different between the HBV-ACLF group with SBP and without. Aspartate aminotransferase (AST), serum sodium, IL-10 and vasoactive drug treatment were independent risk factors for 28-day mortality. International normalized ratio (INR), AST and IL-10 were independent risk factors for 90-day mortality. IL-10 combined with the Chinese Severe Hepatitis B Study Group-ACLF II score (COSH-ACLF IIs) had excellent performance in predicting 28- and 90-day mortality (AUCs: 0.848 and 0.823, respectively). DCA analysis suggests promising clinical utility.ConclusionIL-10 is an independent predictor of mortality at 28- and 90-day in HBV-ACLF patients with SBP and predictive performance is improved when combined with COSH-ACLF IIs.
first_indexed 2024-03-11T21:30:47Z
format Article
id doaj.art-658fa3983d424abcada2ff659cdbd8c1
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-03-11T21:30:47Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-658fa3983d424abcada2ff659cdbd8c12023-09-27T09:16:34ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2023-09-011010.3389/fmed.2023.11883001188300IL-10 predicts the prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure combined with spontaneous bacterial peritonitisLinxiang Liu0Linxiang Liu1Nanxi Xiao2Nanxi Xiao3Peng Chen4Peng Chen5Xuan Zhu6Xuan Zhu7Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaJiangxi Clinical Research Center for Gastroenterology, Nanchang, Jiangxi, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaJiangxi Clinical Research Center for Gastroenterology, Nanchang, Jiangxi, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaJiangxi Clinical Research Center for Gastroenterology, Nanchang, Jiangxi, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaJiangxi Clinical Research Center for Gastroenterology, Nanchang, Jiangxi, ChinaBackgroundSpontaneous bacterial peritonitis (SBP) is common in patients with hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF). The prognostic value of interleukin-related serum markers for patients with ACLF is coming to the fore. However, there is an unmet need to predict the survival of such patients. We aimed to analyze the independent predictors of 28- and 90-day mortality in HBV-ACLF patients with SBP.MethodsThis was a retrospective study that included 368 patients with HBV-ACLF. In the SBP group, logistic regression analysis was used to understand the independent predictors of mortality at 28-day and 90-day. The accuracy of prediction was analyzed using the area under the receiver operating characteristic curve (AUROC). Finally, decision curve analysis (DCA) was used to determine the clinical utility value.ResultsInterleukin 10 (IL-10) levels were statistically significantly different between the HBV-ACLF group with SBP and without. Aspartate aminotransferase (AST), serum sodium, IL-10 and vasoactive drug treatment were independent risk factors for 28-day mortality. International normalized ratio (INR), AST and IL-10 were independent risk factors for 90-day mortality. IL-10 combined with the Chinese Severe Hepatitis B Study Group-ACLF II score (COSH-ACLF IIs) had excellent performance in predicting 28- and 90-day mortality (AUCs: 0.848 and 0.823, respectively). DCA analysis suggests promising clinical utility.ConclusionIL-10 is an independent predictor of mortality at 28- and 90-day in HBV-ACLF patients with SBP and predictive performance is improved when combined with COSH-ACLF IIs.https://www.frontiersin.org/articles/10.3389/fmed.2023.1188300/fullinterleukin 10hepatitis B virusacute-on-chronic liver failureprognosisCOSSH-ACLF II score
spellingShingle Linxiang Liu
Linxiang Liu
Nanxi Xiao
Nanxi Xiao
Peng Chen
Peng Chen
Xuan Zhu
Xuan Zhu
IL-10 predicts the prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure combined with spontaneous bacterial peritonitis
Frontiers in Medicine
interleukin 10
hepatitis B virus
acute-on-chronic liver failure
prognosis
COSSH-ACLF II score
title IL-10 predicts the prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure combined with spontaneous bacterial peritonitis
title_full IL-10 predicts the prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure combined with spontaneous bacterial peritonitis
title_fullStr IL-10 predicts the prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure combined with spontaneous bacterial peritonitis
title_full_unstemmed IL-10 predicts the prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure combined with spontaneous bacterial peritonitis
title_short IL-10 predicts the prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure combined with spontaneous bacterial peritonitis
title_sort il 10 predicts the prognosis of patients with hepatitis b virus related acute on chronic liver failure combined with spontaneous bacterial peritonitis
topic interleukin 10
hepatitis B virus
acute-on-chronic liver failure
prognosis
COSSH-ACLF II score
url https://www.frontiersin.org/articles/10.3389/fmed.2023.1188300/full
work_keys_str_mv AT linxiangliu il10predictstheprognosisofpatientswithhepatitisbvirusrelatedacuteonchronicliverfailurecombinedwithspontaneousbacterialperitonitis
AT linxiangliu il10predictstheprognosisofpatientswithhepatitisbvirusrelatedacuteonchronicliverfailurecombinedwithspontaneousbacterialperitonitis
AT nanxixiao il10predictstheprognosisofpatientswithhepatitisbvirusrelatedacuteonchronicliverfailurecombinedwithspontaneousbacterialperitonitis
AT nanxixiao il10predictstheprognosisofpatientswithhepatitisbvirusrelatedacuteonchronicliverfailurecombinedwithspontaneousbacterialperitonitis
AT pengchen il10predictstheprognosisofpatientswithhepatitisbvirusrelatedacuteonchronicliverfailurecombinedwithspontaneousbacterialperitonitis
AT pengchen il10predictstheprognosisofpatientswithhepatitisbvirusrelatedacuteonchronicliverfailurecombinedwithspontaneousbacterialperitonitis
AT xuanzhu il10predictstheprognosisofpatientswithhepatitisbvirusrelatedacuteonchronicliverfailurecombinedwithspontaneousbacterialperitonitis
AT xuanzhu il10predictstheprognosisofpatientswithhepatitisbvirusrelatedacuteonchronicliverfailurecombinedwithspontaneousbacterialperitonitis